| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1965779 | Clinica Chimica Acta | 2013 | 7 Pages |
Abstract
⺠The SELDI-TOF MS was firstly used to predict outcomes in patients with ACS. ⺠A 4174.39 m/z protein was associated with long-term outcomes in ACS. ⺠CK-MB and troponin T were only associated with short-term outcomes. ⺠The 4174.39 m/z protein provides additional prognostic value in ACS. ⺠The 4174.39 m/z protein may correspond to a member of the CXC chemokine family.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Sheng-Yong Dong, Xiao-Nan Sun, Qiang Zeng, Yang Xu, Jing Sun, Li-Hua Ma,